| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024743 |
| Receipt No. | R000028467 |
| Official scientific title of the study | The analysis of mucosa-associated microbiota in IBD |
| Date of disclosure of the study information | 2016/11/07 |
| Last modified on | 2017/06/19 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | The analysis of mucosa-associated microbiota in IBD | |
| Title of the study (Brief title) | The analysis of mucosa-associated microbiota in IBD | |
| Region |
|
|
| Condition | ||
| Condition | inflammatory bowel disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the components of mucosa-associated in IBD |
| Basic objectives2 | Others |
| Basic objectives -Others | To assess the impact of mucosa-associated microbiota on the pathology of IBD |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The components of mucosa-associated microbiota and the impact on the pathology of IBD |
| Key secondary outcomes | The association of mucosa-associated microbiota and treatment history |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | IBD patients who undergoing gastrointestinal endoscopy
Other patients who undergoing gastrointestinal endoscopy |
|||
| Key exclusion criteria | Patients who reject to participate in this study
Patients with infectious disease that requires notification under the Infectious Diseases Control Law Patients who are considered to be unsuitable to this study for any other reason |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Akira Andoh |
| Organization | Shiga University of Medical Science |
| Division name | Division of Gastroenterology, Department of Medicine |
| Address | Setatsukinowa, Otsu |
| TEL | 077-548-2217 |
| andoh@belle.shiga-med.ac.jp | |
| Public contact | |
| Name of contact person | Atsushi Nishida |
| Organization | Shiga University of Medical Science |
| Division name | Division of Gastroenterology, Department of Medicine |
| Address | Setatsukinowa, Otsu |
| TEL | 077-548-2217 |
| Homepage URL | |
| atsuda@belle.shiga-med.ac.jp | |
| Sponsor | |
| Institute | Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | We aim to clarify the structure and function analysis of mucosa-associated microbiota in patients with inflammatory bowel disease. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028467 |